サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1495344

等温核酸増幅技術（INAAT）市場：世界の産業分析、規模、シェア、成長、動向、予測、2024-2033年

Isothermal Nucleic Acid Amplification Technology Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033

出版日
ページ情報
英文 342 Pages
納期
2～5営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
等温核酸増幅技術（INAAT）市場：世界の産業分析、規模、シェア、成長、動向、予測、2024-2033年
出版日: 2024年06月06日
発行: Persistence Market Research
ページ情報: 英文 342 Pages
納期: 2～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

Persistence Market Research社は、等温核酸増幅技術（INAAT）市場の詳細な分析を発表し、その複雑なダイナミクスと将来の軌道に関する洞察を提供しています。市場動向から成長触媒、阻害要因、新興パターンまで、2024年から2033年までの貴重な統計と予測を提供します。

主な洞察

  • INAAT市場規模（2024年）：52億6,000万米ドル
  • 市場予測値（2033年）：145億6,000万米ドル
  • 世界市場成長率（CAGR 2024年～2033年）：12.0%

INAAT市場- レポート範囲：

INAAT市場は、ヘルスケア、製薬、バイオテクノロジーなどの産業にわたる様々なアプリケーションを包含しています。INAATは核酸の迅速かつ正確な検出に広く使用されており、疾病診断、病原体検出、遺伝子検査に不可欠です。この市場は、病院、診断研究所、研究機関、バイオ製薬会社など幅広いエンドユーザーに対応しており、臨床・研究用途の多い汎用性の高い技術を提供しています。市場成長の原動力は、技術の進歩、ポイントオブケア診断薬に対する需要の増加、感染症の流行といった要因です。

市場促進要因：

世界のINAAT市場は、いくつかの主要な成長促進要因によって支えられています。分子診断の技術的進歩はINAATの効率と応用を強化し、様々な産業での採用を促進します。さらに、特に新興国におけるポイントオブケア診断に対する需要の高まりは、迅速かつ正確な疾患検出のための主要技術として、INAATに対する大きな需要を生み出しています。さらに、感染症の早期かつ正確な診断が重視されるようになったことで、研究開発活動が活発化し、新規のINAATプラットフォームやアッセイの開発が進んでいます。

市場抑制要因：

INAAT市場はその有望な成長見通しにもかかわらず、規制遵守、代替技術との競合、高コストに関する課題に直面しています。診断技術に関する厳しい規制要件は、メーカーやエンドユーザーにコンプライアンス上の負担を課し、市場拡大に影響を与えています。さらに、PCRなど他の核酸増幅技術との競合が、INAATの普及に課題を投げかけています。さらに、INAATプラットフォームや試薬に関連する高コストは市場成長に影響を与える可能性があり、費用対効果の高いソリューションの開発が必要となります。

市場機会：

INAAT市場は、技術革新、業界との提携、市場の多様化によって有利な成長機会をもたらします。個別化医療、感染症の流行、遺伝子研究の進展といった新たな動向は、メーカーが臨床・研究現場におけるINAATの新たな用途や製剤を模索するきっかけとなっています。さらに、戦略的パートナーシップ、共同研究、M&Aにより、市場参入企業は製品ポートフォリオを拡大し、技術力を強化し、主要地域における市場プレゼンスを強化しています。さらに、研究開発への投資の増加と、イノベーションとヘルスケアインフラに対する政府の支援の増加は、市場の拡大と多様化を促進する環境を作り出しています。

本レポートで扱う主な質問

  • INAAT市場の世界的成長を促進する主な要因は何か？
  • 技術の進歩と業界動向は、INAATの用途と製剤の進化をどのように形成しているか？
  • INAAT分野の市場参入企業が直面する主な課題と機会は何か？
  • INAATメーカーが最も成長する可能性のある産業分野と地域はどこか？
  • INAAT製品を差別化し、競合情勢の中で市場シェアを獲得するために、大手企業はどのような戦略を採用しているのか？

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場範囲/ 分類
  • 市場の定義/ 範囲/ 制限

第3章 市場背景

  • 市場力学
  • シナリオ予測
  • 機会マップ分析
  • 投資実現可能性マトリックス
  • PESTLEとポーター分析
  • 規制状況
  • 地域親市場見通し

第4章 世界の等温核酸増幅技術（INAAT）市場分析

  • 過去の市場規模価値（金額）分析、2019年～2023年
  • 現在および将来の市場規模価値（金額）予測、2024年～2033年
    • 前年比成長動向分析
    • 絶対的収益機会分析

第5章 世界の等温核酸増幅技術（INAAT）市場分析：製品別

  • イントロダクション/主な調査結果
  • 過去の市場規模（金額）分析、2019年～2023年
  • 現在および将来の市場規模（金額）分析と予測、2024年～2033年
    • 機器
    • 試薬
  • 前年比成長動向分析、2019年～2023年
  • 絶対的収益機会分析、2024年～2033年

第6章 世界の等温核酸増幅技術（INAAT）市場分析：技術別

  • イントロダクション/主な調査結果
  • 過去の市場規模（金額）分析、2019年～2023年
  • 現在および将来の市場規模（金額）分析と予測、2024年～2033年
    • NASBA
    • HAD
    • LAMP
    • SDA
    • SPIA
    • NEAR
    • TMA
    • RCA
    • RPA
    • SMAP2
    • その他
  • 前年比成長動向分析、2019年～2023年
  • 絶対的収益機会分析、2024年～2033年

第7章 世界の等温核酸増幅技術（INAAT）市場分析：用途別

  • イントロダクション/主な調査結果
  • 過去の市場規模（金額）分析、2019年～2023年
  • 現在および将来の市場規模（金額）分析と予測、2024年～2033年
    • 血液検査
    • 感染症診断
    • がん
    • その他
  • 前年比成長動向分析、2019年～2023年
  • 絶対的収益機会分析、2024年～2033年

第8章 世界の等温核酸増幅技術（INAAT）市場分析：最終用途別

  • イントロダクション/主な調査結果
  • 過去の市場規模（金額）分析、2019年～2023年
  • 現在および将来の市場規模（金額）分析と予測、2024年～2033年
    • 病院
    • セントラルラボおよびリファレンスラボ
    • その他
  • 前年比成長動向分析、2019年～2023年
  • 絶対的収益機会分析、2024年～2033年

第9章 地域別世界等温核酸増幅技術（INAAT）市場分析

  • イントロダクション
  • 過去の市場規模（金額）分析、2019年～2023年
  • 現在の市場規模（金額）分析と予測、2024年～2033年
    • 北米
    • ラテンアメリカ
    • 欧州
    • アジア太平洋地域
    • 中東・アフリカ
  • 地域別市場の魅力分析

第10章 北米の等温核酸増幅技術（INAAT）市場分析（国別）

第11章 ラテンアメリカの等温核酸増幅技術（INAAT）市場分析（国別）

第12章 欧州の等温核酸増幅技術（INAAT）市場分析（国別）

第13章 アジア太平洋地域の等温核酸増幅技術（INAAT）市場分析（国別）

第14章 国別中東・アフリカの等温核酸増幅技術（INAAT）市場分析

第15章 主要国における等温核酸増幅技術（INAAT）市場分析

  • 米国
  • カナダ
  • ブラジル
  • メキシコ
  • ドイツ
  • 英国
  • フランス
  • スペイン
  • イタリア
  • 中国
  • 日本
  • 韓国
  • マレーシア
  • シンガポール
  • オーストラリア
  • ニュージーランド
  • GCC諸国
  • 南アフリカ
  • イスラエル

第16章 市場構造分析

  • 競合ダッシュボード
  • 競合ベンチマーク
  • 主要企業の市場シェア分析

第17章 競合分析

  • 競合の詳細
    • Alere, Inc.
    • bioMerieux SA
    • Eiken Chemical Co. Ltd
    • Hologic Inc.（Gen-Probe）
    • Lucigen
    • Meridian Bioscience, Inc.
    • Ustar Biotechnologies Ltd.
    • QIAGEN
    • Quidel Corporation
    • Thermo Fisher Scientific, Inc.
    • BD（Becton, Dickinson &Company）

第18章 使用される前提条件と頭字語

第19章 調査手法

目次
Product Code: PMRREP33206

Persistence Market Research presents an in-depth analysis of the Isothermal Nucleic Acid Amplification Technology (INAAT) Market, offering insights into its intricate dynamics and future trajectory. From market trends to growth catalysts, impediments, and emerging patterns, this report furnishes invaluable statistics and projections spanning from 2024 to 2033.

Key Insights:

  • INAAT Market Size (2024): USD 5.26 Billion
  • Projected Market Value (2033): USD 14.56 Billion
  • Global Market Growth Rate (CAGR 2024 to 2033): 12.0%

INAAT Market - Report Scope:

The INAAT Market encompasses various applications across industries such as healthcare, pharmaceuticals, and biotechnology. INAAT is widely used for the rapid and accurate detection of nucleic acids, making it essential in disease diagnostics, pathogen detection, and genetic testing. This market caters to a wide range of end-users, including hospitals, diagnostic laboratories, research institutes, and biopharmaceutical companies, offering a versatile technology with numerous clinical and research applications. Market growth is driven by factors such as technological advancements, increasing demand for point-of-care diagnostics, and the rising prevalence of infectious diseases.

Market Growth Drivers:

The global INAAT Market is bolstered by several key growth drivers. Technological advancements in molecular diagnostics enhance the efficiency and applications of INAAT, driving its adoption across various industries. Moreover, the increasing demand for point-of-care diagnostics, especially in emerging economies, creates significant demand for INAAT as a key technology for rapid and accurate disease detection. Additionally, the growing emphasis on early and precise diagnosis of infectious diseases stimulates research and development activities, leading to the development of novel INAAT platforms and assays.

Market Restraints:

Despite its promising growth prospects, the INAAT Market faces challenges related to regulatory compliance, competition from alternative technologies, and high costs. Stringent regulatory requirements regarding diagnostic technologies impose compliance burdens on manufacturers and end-users, impacting market expansion. Furthermore, competition from other nucleic acid amplification technologies, such as PCR, poses challenges to the widespread adoption of INAAT. Additionally, the high costs associated with INAAT platforms and reagents can affect market growth, necessitating the development of cost-effective solutions.

Market Opportunities:

The INAAT Market presents lucrative growth opportunities driven by technological innovation, industry collaborations, and market diversification. Emerging trends such as personalized medicine, infectious disease outbreaks, and advancements in genetic research inspire manufacturers to explore new applications and formulations for INAAT in clinical and research settings. Moreover, strategic partnerships, research collaborations, and mergers and acquisitions enable market players to expand their product portfolios, enhance their technical capabilities, and strengthen their market presence in key regions. Furthermore, growing investments in research and development, coupled with increasing government support for innovation and healthcare infrastructure, create a conducive environment for market expansion and diversification.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the INAAT Market globally?
  • How are technological advancements and industry trends shaping the evolution of INAAT applications and formulations?
  • What are the key challenges and opportunities facing market participants in the INAAT segment?
  • Which industrial sectors and geographic regions offer the highest growth potential for INAAT manufacturers?
  • What strategies are leading companies employing to differentiate their INAAT offerings and capture market share in the competitive diagnostic landscape?

Competitive Intelligence and Business Strategy:

Leading players in the global INAAT Market, including diagnostic companies, pharmaceutical firms, and biotechnology enterprises, focus on innovation, product differentiation, and market expansion to gain a competitive edge. These companies invest in research and development to develop advanced INAAT technologies, improve product quality, and explore new applications for INAAT in various industries. Moreover, strategic collaborations with research institutions, academic partners, and industry associations enable market players to access new technologies, expand their knowledge base, and accelerate product development efforts. Furthermore, emphasis on regulatory compliance, quality assurance, and customer support enhances brand reputation and fosters long-term relationships with customers and stakeholders.

Key Companies Profiled:

  • Alere, Inc.
  • bioMerieux SA
  • Eiken Chemical Co. Ltd
  • Hologic Inc.(Gen-Probe)
  • Lucigen
  • Meridian Bioscience, Inc.
  • Ustar Biotechnologies Ltd.
  • QIAGEN
  • Quidel Corporation
  • Thermo Fisher Scientific, Inc.
  • BD (Becton, Dickinson & Company)
  • OptiGene Limited

INAAT Market Research Segmentation:

By Product Type

  • Instruments
  • Reagent

By Technology

  • NASBA
  • HDA
  • LAMP
  • SDA
  • SPIA
  • NEAR
  • TMA
  • RCA
  • RPA
  • SMAP2
  • Others

By Application

  • Blood Screening
  • Infectious Disease Diagnostics
  • Cancer
  • Others

By End User

  • Hospitals
  • Central & Reference Labs
  • Others

By Region

  • North America Market
  • Europe Market
  • Asia Pacific Market
  • Middle East & Africa Market
  • South America Market

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand-side Trends
  • 1.3. Supply-side Trends
  • 1.4. Technology Roadmap Analysis
  • 1.5. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations

3. Market Background

  • 3.1. Market Dynamics
    • 3.1.1. Drivers
    • 3.1.2. Restraints
    • 3.1.3. Opportunity
    • 3.1.4. Trends
  • 3.2. Scenario Forecast
    • 3.2.1. Demand in Optimistic Scenario
    • 3.2.2. Demand in Likely Scenario
    • 3.2.3. Demand in Conservative Scenario
  • 3.3. Opportunity Map Analysis
  • 3.4. Investment Feasibility Matrix
  • 3.5. PESTLE and Porter's Analysis
  • 3.6. Regulatory Landscape
    • 3.6.1. By Key Regions
    • 3.6.2. By Key Countries
  • 3.7. Regional Parent Market Outlook

4. Global Isothermal Nucleic Acid Amplification Technology Market Analysis 2019-2023 and Forecast, 2024-2033

  • 4.1. Historical Market Size Value (US$ Bn) Analysis, 2019-2023
  • 4.2. Current and Future Market Size Value (US$ Bn) Projections, 2024-2033
    • 4.2.1. Y-o-Y Growth Trend Analysis
    • 4.2.2. Absolute $ Opportunity Analysis

5. Global Isothermal Nucleic Acid Amplification Technology Market Analysis 2019-2023 and Forecast 2024-2033, By Product

  • 5.1. Introduction / Key Findings
  • 5.2. Historical Market Size Value (US$ Bn) Analysis By Product , 2019-2023
  • 5.3. Current and Future Market Size Value (US$ Bn) Analysis and Forecast By Product , 2024-2033
    • 5.3.1. Instruments
    • 5.3.2. Reagent
  • 5.4. Y-o-Y Growth Trend Analysis By Product , 2019-2023
  • 5.5. Absolute $ Opportunity Analysis By Product , 2024-2033

6. Global Isothermal Nucleic Acid Amplification Technology Market Analysis 2019-2023 and Forecast 2024-2033, By Technology

  • 6.1. Introduction / Key Findings
  • 6.2. Historical Market Size Value (US$ Bn) Analysis By Technology, 2019-2023
  • 6.3. Current and Future Market Size Value (US$ Bn) Analysis and Forecast By Technology, 2024-2033
    • 6.3.1. NASBA
    • 6.3.2. HAD
    • 6.3.3. LAMP
    • 6.3.4. SDA
    • 6.3.5. SPIA
    • 6.3.6. NEAR
    • 6.3.7. TMA
    • 6.3.8. RCA
    • 6.3.9. RPA
    • 6.3.10. SMAP2
    • 6.3.11. Others
  • 6.4. Y-o-Y Growth Trend Analysis By Technology, 2019-2023
  • 6.5. Absolute $ Opportunity Analysis By Technology, 2024-2033

7. Global Isothermal Nucleic Acid Amplification Technology Market Analysis 2019-2023 and Forecast 2024-2033, By Application

  • 7.1. Introduction / Key Findings
  • 7.2. Historical Market Size Value (US$ Bn) Analysis By Application , 2019-2023
  • 7.3. Current and Future Market Size Value (US$ Bn) Analysis and Forecast By Application , 2024-2033
    • 7.3.1. Blood Screening
    • 7.3.2. Infectious Disease Diagnostics
    • 7.3.3. Cancer
    • 7.3.4. Others
  • 7.4. Y-o-Y Growth Trend Analysis By Application , 2019-2023
  • 7.5. Absolute $ Opportunity Analysis By Application , 2024-2033

8. Global Isothermal Nucleic Acid Amplification Technology Market Analysis 2019-2023 and Forecast 2024-2033, By End-use

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size Value (US$ Bn) Analysis By End-use, 2019-2023
  • 8.3. Current and Future Market Size Value (US$ Bn) Analysis and Forecast By End-use, 2024-2033
    • 8.3.1. Hospitals
    • 8.3.2. Central & Reference Labs
    • 8.3.3. Others
  • 8.4. Y-o-Y Growth Trend Analysis By End-use, 2019-2023
  • 8.5. Absolute $ Opportunity Analysis By End-use, 2024-2033

9. Global Isothermal Nucleic Acid Amplification Technology Market Analysis 2019-2023 and Forecast 2024-2033, By Region

  • 9.1. Introduction
  • 9.2. Historical Market Size Value (US$ Bn) Analysis By Region, 2019-2023
  • 9.3. Current Market Size Value (US$ Bn) Analysis and Forecast By Region, 2024-2033
    • 9.3.1. North America
    • 9.3.2. Latin America
    • 9.3.3. Europe
    • 9.3.4. Asia Pacific
    • 9.3.5. MEA
  • 9.4. Market Attractiveness Analysis By Region

10. North America Isothermal Nucleic Acid Amplification Technology Market Analysis 2019-2023 and Forecast 2024-2033, By Country

  • 10.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
  • 10.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2024-2033
    • 10.2.1. By Country
      • 10.2.1.1. U.S.
      • 10.2.1.2. Canada
    • 10.2.2. By Product
    • 10.2.3. By Technology
    • 10.2.4. By Application
    • 10.2.5. By End-use
  • 10.3. Market Attractiveness Analysis
    • 10.3.1. By Country
    • 10.3.2. By Product
    • 10.3.3. By Technology
    • 10.3.4. By Application
    • 10.3.5. By End-use
  • 10.4. Key Takeaways

11. Latin America Isothermal Nucleic Acid Amplification Technology Market Analysis 2019-2023 and Forecast 2024-2033, By Country

  • 11.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
  • 11.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2024-2033
    • 11.2.1. By Country
      • 11.2.1.1. Brazil
      • 11.2.1.2. Mexico
      • 11.2.1.3. Rest of Latin America
    • 11.2.2. By Product
    • 11.2.3. By Technology
    • 11.2.4. By Application
    • 11.2.5. By End-use
  • 11.3. Market Attractiveness Analysis
    • 11.3.1. By Country
    • 11.3.2. By Product
    • 11.3.3. By Technology
    • 11.3.4. By Application
    • 11.3.5. By End-use
  • 11.4. Key Takeaways

12. Europe Isothermal Nucleic Acid Amplification Technology Market Analysis 2019-2023 and Forecast 2024-2033, By Country

  • 12.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
  • 12.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2024-2033
    • 12.2.1. By Country
      • 12.2.1.1. Germany
      • 12.2.1.2. U.K.
      • 12.2.1.3. France
      • 12.2.1.4. Spain
      • 12.2.1.5. Italy
      • 12.2.1.6. Rest of Europe
    • 12.2.2. By Product
    • 12.2.3. By Technology
    • 12.2.4. By Application
    • 12.2.5. By End-use
  • 12.3. Market Attractiveness Analysis
    • 12.3.1. By Country
    • 12.3.2. By Product
    • 12.3.3. By Technology
    • 12.3.4. By Application
    • 12.3.5. By End-use
  • 12.4. Key Takeaways

13. Asia Pacific Isothermal Nucleic Acid Amplification Technology Market Analysis 2019-2023 and Forecast 2024-2033, By Country

  • 13.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
  • 13.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2024-2033
    • 13.2.1. By Country
      • 13.2.1.1. China
      • 13.2.1.2. Japan
      • 13.2.1.3. South Korea
      • 13.2.1.4. India
      • 13.2.1.5. Malaysia
      • 13.2.1.6. Singapore
      • 13.2.1.7. Australia
      • 13.2.1.8. New Zealand
      • 13.2.1.9. Rest of APAC
    • 13.2.2. By Product
    • 13.2.3. By Technology
    • 13.2.4. By Application
    • 13.2.5. By End-use
  • 13.3. Market Attractiveness Analysis
    • 13.3.1. By Country
    • 13.3.2. By Product
    • 13.3.3. By Technology
    • 13.3.4. By Application
    • 13.3.5. By End-use
  • 13.4. Key Takeaways

14. MEA Isothermal Nucleic Acid Amplification Technology Market Analysis 2019-2023 and Forecast 2024-2033, By Country

  • 14.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
  • 14.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2024-2033
    • 14.2.1. By Country
      • 14.2.1.1. GCC Countries
      • 14.2.1.2. South Africa
      • 14.2.1.3. Israel
      • 14.2.1.4. Rest of MEA
    • 14.2.2. By Product
    • 14.2.3. By Technology
    • 14.2.4. By Application
    • 14.2.5. By End-use
  • 14.3. Market Attractiveness Analysis
    • 14.3.1. By Country
    • 14.3.2. By Product
    • 14.3.3. By Technology
    • 14.3.4. By Application
    • 14.3.5. By End-use
  • 14.4. Key Takeaways

15. Key Countries Isothermal Nucleic Acid Amplification Technology Market Analysis

  • 15.1. U.S.
    • 15.1.1. Pricing Analysis
    • 15.1.2. Market Share Analysis, 2024
      • 15.1.2.1. By Product
      • 15.1.2.2. By Technology
      • 15.1.2.3. By Application
      • 15.1.2.4. By End-use
  • 15.2. Canada
    • 15.2.1. Pricing Analysis
    • 15.2.2. Market Share Analysis, 2024
      • 15.2.2.1. By Product
      • 15.2.2.2. By Technology
      • 15.2.2.3. By Application
      • 15.2.2.4. By End-use
  • 15.3. Brazil
    • 15.3.1. Pricing Analysis
    • 15.3.2. Market Share Analysis, 2024
      • 15.3.2.1. By Product
      • 15.3.2.2. By Technology
      • 15.3.2.3. By Application
      • 15.3.2.4. By End-use
  • 15.4. Mexico
    • 15.4.1. Pricing Analysis
    • 15.4.2. Market Share Analysis, 2024
      • 15.4.2.1. By Product
      • 15.4.2.2. By Technology
      • 15.4.2.3. By Application
      • 15.4.2.4. By End-use
  • 15.5. Germany
    • 15.5.1. Pricing Analysis
    • 15.5.2. Market Share Analysis, 2024
      • 15.5.2.1. By Product
      • 15.5.2.2. By Technology
      • 15.5.2.3. By Application
      • 15.5.2.4. By End-use
  • 15.6. U.K.
    • 15.6.1. Pricing Analysis
    • 15.6.2. Market Share Analysis, 2024
      • 15.6.2.1. By Product
      • 15.6.2.2. By Technology
      • 15.6.2.3. By Application
      • 15.6.2.4. By End-use
  • 15.7. France
    • 15.7.1. Pricing Analysis
    • 15.7.2. Market Share Analysis, 2024
      • 15.7.2.1. By Product
      • 15.7.2.2. By Technology
      • 15.7.2.3. By Application
      • 15.7.2.4. By End-use
  • 15.8. Spain
    • 15.8.1. Pricing Analysis
    • 15.8.2. Market Share Analysis, 2024
      • 15.8.2.1. By Product
      • 15.8.2.2. By Technology
      • 15.8.2.3. By Application
      • 15.8.2.4. By End-use
  • 15.9. Italy
    • 15.9.1. Pricing Analysis
    • 15.9.2. Market Share Analysis, 2024
      • 15.9.2.1. By Product
      • 15.9.2.2. By Technology
      • 15.9.2.3. By Application
      • 15.9.2.4. By End-use
  • 15.10. China
    • 15.10.1. Pricing Analysis
    • 15.10.2. Market Share Analysis, 2024
      • 15.10.2.1. By Product
      • 15.10.2.2. By Technology
      • 15.10.2.3. By Application
      • 15.10.2.4. By End-use
  • 15.11. Japan
    • 15.11.1. Pricing Analysis
    • 15.11.2. Market Share Analysis, 2024
      • 15.11.2.1. By Product
      • 15.11.2.2. By Technology
      • 15.11.2.3. By Application
      • 15.11.2.4. By End-use
  • 15.12. South Korea
    • 15.12.1. Pricing Analysis
    • 15.12.2. Market Share Analysis, 2024
      • 15.12.2.1. By Product
      • 15.12.2.2. By Technology
      • 15.12.2.3. By Application
      • 15.12.2.4. By End-use
  • 15.13. Malaysia
    • 15.13.1. Pricing Analysis
    • 15.13.2. Market Share Analysis, 2024
      • 15.13.2.1. By Product
      • 15.13.2.2. By Technology
      • 15.13.2.3. By Application
      • 15.13.2.4. By End-use
  • 15.14. Singapore
    • 15.14.1. Pricing Analysis
    • 15.14.2. Market Share Analysis, 2024
      • 15.14.2.1. By Product
      • 15.14.2.2. By Technology
      • 15.14.2.3. By Application
      • 15.14.2.4. By End-use
  • 15.15. Australia
    • 15.15.1. Pricing Analysis
    • 15.15.2. Market Share Analysis, 2024
      • 15.15.2.1. By Product
      • 15.15.2.2. By Technology
      • 15.15.2.3. By Application
      • 15.15.2.4. By End-use
  • 15.16. New Zealand
    • 15.16.1. Pricing Analysis
    • 15.16.2. Market Share Analysis, 2024
      • 15.16.2.1. By Product
      • 15.16.2.2. By Technology
      • 15.16.2.3. By Application
      • 15.16.2.4. By End-use
  • 15.17. GCC Countries
    • 15.17.1. Pricing Analysis
    • 15.17.2. Market Share Analysis, 2024
      • 15.17.2.1. By Product
      • 15.17.2.2. By Technology
      • 15.17.2.3. By Application
      • 15.17.2.4. By End-use
  • 15.18. South Africa
    • 15.18.1. Pricing Analysis
    • 15.18.2. Market Share Analysis, 2024
      • 15.18.2.1. By Product
      • 15.18.2.2. By Technology
      • 15.18.2.3. By Application
      • 15.18.2.4. By End-use
  • 15.19. Israel
    • 15.19.1. Pricing Analysis
    • 15.19.2. Market Share Analysis, 2024
      • 15.19.2.1. By Product
      • 15.19.2.2. By Technology
      • 15.19.2.3. By Application
      • 15.19.2.4. By End-use

16. Market Structure Analysis

  • 16.1. Competition Dashboard
  • 16.2. Competition Benchmarking
  • 16.3. Market Share Analysis of Top Players
    • 16.3.1. By Regional
    • 16.3.2. By Product
    • 16.3.3. By Technology
    • 16.3.4. By Application
    • 16.3.5. By End-use

17. Competition Analysis

  • 17.1. Competition Deep Dive
    • 17.1.1. Alere, Inc.
      • 17.1.1.1. Overview
      • 17.1.1.2. Product Portfolio
      • 17.1.1.3. Profitability by Market Segments
      • 17.1.1.4. Sales Footprint
      • 17.1.1.5. Strategy Overview
        • 17.1.1.5.1. Marketing Strategy
    • 17.1.2. bioMerieux SA
      • 17.1.2.1. Overview
      • 17.1.2.2. Product Portfolio
      • 17.1.2.3. Profitability by Market Segments
      • 17.1.2.4. Sales Footprint
      • 17.1.2.5. Strategy Overview
        • 17.1.2.5.1. Marketing Strategy
    • 17.1.3. Eiken Chemical Co. Ltd
      • 17.1.3.1. Overview
      • 17.1.3.2. Product Portfolio
      • 17.1.3.3. Profitability by Market Segments
      • 17.1.3.4. Sales Footprint
      • 17.1.3.5. Strategy Overview
        • 17.1.3.5.1. Marketing Strategy
    • 17.1.4. Hologic Inc.(Gen-Probe)
      • 17.1.4.1. Overview
      • 17.1.4.2. Product Portfolio
      • 17.1.4.3. Profitability by Market Segments
      • 17.1.4.4. Sales Footprint
      • 17.1.4.5. Strategy Overview
        • 17.1.4.5.1. Marketing Strategy
    • 17.1.5. Lucigen
      • 17.1.5.1. Overview
      • 17.1.5.2. Product Portfolio
      • 17.1.5.3. Profitability by Market Segments
      • 17.1.5.4. Sales Footprint
      • 17.1.5.5. Strategy Overview
        • 17.1.5.5.1. Marketing Strategy
    • 17.1.6. Meridian Bioscience, Inc.
      • 17.1.6.1. Overview
      • 17.1.6.2. Product Portfolio
      • 17.1.6.3. Profitability by Market Segments
      • 17.1.6.4. Sales Footprint
      • 17.1.6.5. Strategy Overview
        • 17.1.6.5.1. Marketing Strategy
    • 17.1.7. Ustar Biotechnologies Ltd.
      • 17.1.7.1. Overview
      • 17.1.7.2. Product Portfolio
      • 17.1.7.3. Profitability by Market Segments
      • 17.1.7.4. Sales Footprint
      • 17.1.7.5. Strategy Overview
        • 17.1.7.5.1. Marketing Strategy
    • 17.1.8. QIAGEN
      • 17.1.8.1. Overview
      • 17.1.8.2. Product Portfolio
      • 17.1.8.3. Profitability by Market Segments
      • 17.1.8.4. Sales Footprint
      • 17.1.8.5. Strategy Overview
        • 17.1.8.5.1. Marketing Strategy
    • 17.1.9. Quidel Corporation
      • 17.1.9.1. Overview
      • 17.1.9.2. Product Portfolio
      • 17.1.9.3. Profitability by Market Segments
      • 17.1.9.4. Sales Footprint
      • 17.1.9.5. Strategy Overview
        • 17.1.9.5.1. Marketing Strategy
    • 17.1.10. Thermo Fisher Scientific, Inc.
      • 17.1.10.1. Overview
      • 17.1.10.2. Product Portfolio
      • 17.1.10.3. Profitability by Market Segments
      • 17.1.10.4. Sales Footprint
      • 17.1.10.5. Strategy Overview
        • 17.1.10.5.1. Marketing Strategy
    • 17.1.11. BD (Becton, Dickinson & Company)
      • 17.1.11.1. Overview
      • 17.1.11.2. Product Portfolio
      • 17.1.11.3. Profitability by Market Segments
      • 17.1.11.4. Sales Footprint
      • 17.1.11.5. Strategy Overview
        • 17.1.11.5.1. Marketing Strategy

18. Assumptions & Acronyms Used

19. Research Methodology